Instalab

Pyroglutamate Test

An early window into oxidative stress and your body's antioxidant recycling, measured in your urine.

Who benefits from Pyroglutamate testing

Taking Acetaminophen Regularly
This test can show whether long-term use is depleting your body's main antioxidant recycling system.
Living With an Autoimmune Condition
Higher levels have been linked to active autoimmune disease and may add context to inflammation markers you already track.
Managing Chronic Pain
Chronic pain depletes antioxidant capacity, and this marker offers a way to see whether that system is keeping up.
Building Your Oxidative Stress Picture
A research-tier marker that gives you an early window into how well your cells are recycling glutathione.

About Pyroglutamate

Glutathione is your body's most important built-in antioxidant, the molecule your cells use to neutralize damage from normal metabolism. When that recycling system gets stressed or starts to falter, an intermediate called pyroglutamate (also called 5-oxoproline) tends to accumulate and spill into urine. Measuring it gives you a window into how hard your antioxidant machinery is working.

This is a research-tier marker, not a routine lab. Standardized clinical cutpoints do not yet exist for healthy adults, but elevated levels have been linked to autoimmune disease, oxidative stress in critical illness, chronic pain, and chronic acetaminophen use. A baseline gives you something to track as the science matures.

What This Test Actually Measures

Pyroglutamate is a cyclized form of the amino acid glutamate. It sits inside the gamma-glutamyl cycle, the chemical loop your cells use to make and recycle glutathione. When glutathione production is overwhelmed or partially blocked, the loop backs up and pyroglutamate accumulates in tissues, blood, and urine.

This urine test measures pyroglutamate excretion. Because the kidney clears it efficiently, urinary levels reflect what your body is producing rather than what it is storing. Higher excretion generally signals that the glutathione recycling system is under more strain than usual.

Why It Matters: Oxidative Stress and Glutathione

Glutathione is the workhorse antioxidant inside almost every cell. It scavenges damaging molecules produced during normal metabolism, helps repair proteins and DNA, and supports detoxification by the liver. When demand for glutathione exceeds supply, the body shows it through metabolic side effects, and pyroglutamate is one of them.

In a retrospective analysis of 17,834 chronic pain patients, about 19% had elevated urinary pyroglutamate, interpreted as a sign of glutathione depletion. The same pattern shows up in critically ill people, in some autoimmune diseases, and in people on long-term acetaminophen, all situations where antioxidant capacity is being heavily taxed.

Autoimmune Disease (Lupus)

In a study of 123 people, those with systemic lupus erythematosus (an autoimmune disease often shortened to SLE) had higher serum L-pyroglutamic acid than healthy controls. The marker separated the two groups very accurately, catching about 97 out of 100 lupus cases while correctly clearing about 83 out of 100 healthy people. Higher levels also tracked with disease activity scores and inflammatory markers.

That study measured serum, not urine, so the same diagnostic accuracy has not been confirmed for urinary pyroglutamate specifically. Still, the finding suggests that the glutathione system is meaningfully disturbed in active autoimmunity, and that pyroglutamate is one of the clearest readouts of that disturbance.

Critical Illness and Sepsis

In 28 people in intensive care with septic shock, both serum and urine pyroglutamate were higher than in healthy controls, and the elevation correlated with depletion of glutathione and signs of oxidative stress. A separate prospective study of 40 patients with high anion gap metabolic acidosis (a serious blood chemistry imbalance) found that pyroglutamate was a meaningful contributor in about 6% of cases, particularly in septic shock.

You will not be ordering this test mid-ICU stay. The relevance for a healthy adult is that the same pathway, glutathione recycling under stress, can be tracked in milder forms during everyday life, particularly in people whose bodies are chronically taxed by inflammation, illness, or heavy medication use.

Chronic Pain and Glutathione Depletion

Chronic pain is biologically expensive. The body produces more reactive oxygen molecules during ongoing inflammation, and the antioxidant system has to work harder. In the 17,834-patient chronic pain cohort, urinary pyroglutamate was used as part of a panel to flag people whose glutathione reserves were stretched thin.

Roughly one in five had elevated levels. The authors interpret this as a sign of reduced capacity to handle additional oxidative stress, including from medications like acetaminophen, which itself depletes glutathione. If you live with chronic pain or take a lot of acetaminophen, this marker can give you a sense of how the underlying chemistry is holding up.

Inborn Errors and Drug-Induced Acidosis

At very high levels, pyroglutamate can drive a serious blood chemistry problem called high anion gap metabolic acidosis. The classic causes are an inherited enzyme deficiency (glutathione synthetase deficiency, usually identified in infancy) and an acquired form linked to chronic acetaminophen use, especially when combined with antibiotics like flucloxacillin and accompanied by malnutrition or sepsis.

For most adults ordering this test, that severe scenario is not what you are screening for. But the same biology applies in milder form: long-term high-dose acetaminophen use can deplete glutathione enough to push pyroglutamate up, even when the blood chemistry stays normal.

How to Read Your Result

This is a Tier 3 research marker without universally agreed-upon cutpoints. Reference values come from the lab running the test and from research populations, not from a major guideline body. The single most useful rule is to compare your future readings to your own baseline using the same lab and the same method.

In the chronic pain study, about 19% of urine samples were classified as elevated against the lab's reference range. In the lupus study, serum levels above roughly 61.5 micromolar (a unit for very small concentrations in blood) flagged most lupus cases. Your urine result will be reported in different units and against a different range. Treat the lab's flag as a starting point, not a verdict.

TierWhat It Suggests
Within lab reference rangeGlutathione recycling appears to be keeping up with current demand.
Mildly above reference rangePossible early sign of glutathione strain. Worth retesting and reviewing acetaminophen use, sleep, and chronic stressors.
Substantially above reference rangeSuggests meaningful glutathione depletion or oxidative stress. Pair with related tests and look for an underlying driver.

Tracking Your Trend

A single pyroglutamate reading is most useful as the first point on a line. Levels can shift with illness, medication use, and chronic stress, and the marker has no universally validated decision threshold for healthy adults. What you can act on is the direction of change over time, especially after you change something that should affect glutathione status.

A reasonable cadence: get a baseline, retest in 3 to 6 months if you are making changes (cutting back on acetaminophen, addressing chronic inflammation, treating an autoimmune condition), and at least annually if you are tracking it as part of a broader oxidative stress picture. Use the same lab each time so the numbers are comparable.

What an Elevated Result Should Make You Do

An elevated pyroglutamate is a prompt to investigate, not a diagnosis on its own. The most useful next step is to look at the surrounding picture: your acetaminophen use, your inflammatory markers (hs-CRP, the high-sensitivity version of C-reactive protein), your kidney function, and any signs of an autoimmune process if you have symptoms.

If you take acetaminophen daily or near-daily, the simplest first move is to reduce that exposure and retest in a few months. If you have known autoimmune disease or chronic inflammation, share the result with the specialist managing that condition. If your pyroglutamate is high without an obvious explanation and you have unexplained fatigue, joint pain, or rashes, an autoimmune workup including ANA (a lupus screening test) is reasonable to discuss.

When Results Can Be Misleading

  • Recent acetaminophen use: Even short-term acetaminophen exposure depletes glutathione and can transiently raise pyroglutamate. If you have taken acetaminophen in the days before the test, your result may overstate your usual baseline.
  • Acute illness: Infections, surgery, and severe stress all increase oxidative load. A reading taken during or shortly after an acute illness can run higher than your true steady state. Wait until you have recovered before testing.
  • Kidney function: Because pyroglutamate is cleared by the kidneys, abnormal kidney filtration can change urinary levels independent of glutathione status. Pair this test with kidney function markers if you have known kidney disease.
  • Collection variability: Urine concentration varies with hydration. A very dilute or very concentrated sample can shift the absolute number. Most labs adjust pyroglutamate against urinary creatinine to correct for this; make sure your lab does.

What Moves This Biomarker

Evidence-backed interventions that affect your Pyroglutamate level

Increase
Take acetaminophen (paracetamol) regularly, especially long-term or at high doses
Chronic acetaminophen use depletes glutathione and is the most consistently identified driver of elevated urinary pyroglutamate in adults. In a systematic review and case series, chronic acetaminophen exposure, often combined with malnutrition or other risk factors, was the primary acquired cause of pyroglutamate accumulation severe enough to cause metabolic acidosis. Even subclinical doses appear to push the marker upward by stressing the glutathione recycling system.
MedicationStrong Evidence
Increase
Take flucloxacillin or other beta-lactamase-resistant penicillins, especially with acetaminophen
These antibiotics interfere with the gamma-glutamyl cycle and, particularly when combined with acetaminophen, drive pyroglutamate accumulation. The combination is the classic trigger of acquired pyroglutamic acidosis described in case reports and a systematic review. The effect is meaningful enough that the combination is flagged in drug safety literature.
MedicationStrong Evidence
Increase
Sustained undernutrition or low protein intake
Chronic undernutrition limits the supply of cysteine and glycine, the building blocks of glutathione, and is a recurring risk factor for pyroglutamate elevation in adult case series. People who develop drug-related pyroglutamic acidosis are disproportionately undernourished, suggesting that low substrate availability amplifies the impact of acetaminophen and other triggers on the glutathione cycle.
LifestyleModerate Evidence

Frequently Asked Questions

References

9 studies
  1. Qiong Zhang, Xin Li, Xiaofeng Yin, Haifang Wang, Chen Fu, Hong Wang, Kaifei Li, Yao Li, Xiaohe Zhang, Huijun Liang, Kui Li, Haixia Li, Yurong QiuRheumatology2020
  2. Y. Gamarra, F. Santiago, J. Molina-lópez, J. Castaño, L. Herrera-quintana, Á. Domínguez, E. PlanellsCritical Care2019
  3. J. Gunn, M. M. Hill, B. Cotten, T. DeerPain Physician2020
  4. Tessa Scafetta, O. Kovács, G. Milani, Gabriel Bronz, S. Lava, C. Betti, Federica Vanoni, M. Bianchetti, Pietro B. Faré, Pietro CamozziJournal of Clinical Medicine2024